| Open Document File Size: 27,64 KBShare Result on Facebook
City Cambridge / / Company Novartis / The Medicines Company / Regulus Therapeutics Inc. / Alnylam Pharmaceuticals Alnylam / Takeda / Biogen Idec / Cubist / Monsanto / Sirna Therapeutics / Roche / Genzyme / Sanofi company / Medtronic / GlaxoSmithKline / Ascletis / Merck / New England Journal / Kyowa Hakko Kirin / Alnylam Pharmaceuticals Inc. / / Continent North America / Europe / / Currency USD / / Event Business Partnership / Funding / Conference Call / M&A / FDA Phase / / Facility Genetic Medicines Pipeline / Genzyme's pipeline / RNAi Therapeutic Genetic Medicine Pipeline / / IndustryTerm owned subsidiary / treatment of serious / life-threatening diseases / treatment of AAT deficiency liver disease / others developing products / codevelop/co-promote products / biopharmaceutical / treatment of complement-mediated diseases / others using technology / treatment of genetic diseases / biopharmaceutical company developing novel therapeutics / therapeutic products / treatment of hemophilia / / MedicalCondition both familial cardiac amyloidosis / rare diseases / mixed hyperlipidemia / acute intermittent porphyria / rare genetic diseases / iron-overload disorders / polyneuropathy / beta-thalassemia / Familial Amyloidotic Polyneuropathy / AAT deficiency liver disease / porphyria / hemophilia / TTR-mediated amyloidosis / hepatic porphyrias / complement-mediated diseases / disease / senile systemic amyloidosis / rare bleeding disorders / TTR amyloid cardiomyopathy / familial amyloidotic cardiomyopathy / genetic diseases / amyloidosis / severe hypertriglyceridemia / diseases / TTR cardiac amyloidosis / hypercholesterolemia / / Organization U.S. Securities and Exchange Commission / Transformational Alliance / Securities and Exchange Commission / / Person David Meeker / John Maraganore / / / Position board member / Chief Executive Officer / President and Chief Executive Officer / / Product RNAi / 5x15 / RNAi therapeutic platform / TTR02 / Alnylam RNAi / Alnylam 5x15 / / ProvinceOrState Massachusetts / / PublishedMedium Nature Biotechnology / Nature Medicine / the New England Journal of Medicine / / Region Western Europe / / Technology alpha / Biotechnology / others using technology / drug discovery / RNAi technology / drug development / / URL www.alnylam.com / /
SocialTag |
January 13, 2014 Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines - New Collaboration Expected to Accelerate and Expand Global Product Value for RNAi Therapeutic Genetic Medi